| Global strategy for asthma management and prevention: GINA executive summary ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ... European Respiratory Journal 31 (1), 143-178, 2008 | 4420 | 2008 |
| Clinical trial registration: a statement from the International Committee of Medical Journal Editors C De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, S Kotzin, ... The Lancet 364 (9438), 911-912, 2004 | 2457 | 2004 |
| Statistics in medicine—reporting of subgroup analyses in clinical trials R Wang, SW Lagakos, JH Ware, DJ Hunter, JM Drazen New England Journal of Medicine 357 (21), 2189-2194, 2007 | 1494 | 2007 |
| The biology of nitrogen oxides in the airways. B Gaston, JM Drazen, J Loscalzo, JS Stamler American journal of respiratory and critical care medicine 149 (2), 538-551, 1994 | 1192 | 1994 |
| Treatment of asthma with drugs modifying the leukotriene pathway JM Drazen, E Israel, PM O'Byrne New England Journal of Medicine 340 (3), 197-206, 1999 | 1172 | 1999 |
| A summary of the new GINA strategy: a roadmap to asthma control HK Reddel, ED Bateman, A Becker, LP Boulet, AA Cruz, JM Drazen, ... European Respiratory Journal 46 (3), 622-639, 2015 | 1027 | 2015 |
| Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ... Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010 | 1016 | 2010 |
| Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization L Kobzik, DS Bredt, CJ Lowenstein, J Drazen, B Gaston, D Sugarbaker, ... American journal of respiratory cell and molecular biology 9, 371-371, 1993 | 1000 | 1993 |
| Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes HK Reddel, LB Bacharier, ED Bateman, CE Brightling, GG Brusselle, ... American journal of respiratory and critical care medicine 205 (1), 17-35, 2022 | 937 | 2022 |
| Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet S Finotto, MF Neurath, JN Glickman, S Qin, HA Lehr, FHY Green, ... Science 295 (5553), 336-338, 2002 | 921 | 2002 |
| Sponsorship, authorship, and accountability F Davidoff, CD DeAngelis, JM Drazen, J Hoey, L Højgaard, R Horton, ... The Lancet 358 (9285), 854-856, 2001 | 866 | 2001 |
| Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. JM Drazen, KF Austen, RA Lewis, DA Clark, G Goto, A Marfat, EJ Corey Proceedings of the National Academy of Sciences 77 (7), 4354-4358, 1980 | 860 | 1980 |
| Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. B Gaston, J Reilly, JM Drazen, J Fackler, P Ramdev, D Arnelle, ... Proceedings of the National Academy of Sciences 90 (23), 10957-10961, 1993 | 801 | 1993 |
| Evidence for health decision making—beyond randomized, controlled trials TR Frieden New England Journal of Medicine 377 (5), 465-475, 2017 | 769 | 2017 |
| Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. K Asano, CB Chee, B Gaston, CM Lilly, C Gerard, JM Drazen, JS Stamler Proceedings of the National Academy of Sciences 91 (21), 10089-10093, 1994 | 763 | 1994 |
| Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment JM Drazen, CN Yandava, L Dubé, N Szczerback, R Hippensteel, A Pillari, ... Nature genetics 22 (2), 168-170, 1999 | 747 | 1999 |
| Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ... The Lancet 364 (9444), 1505-1512, 2004 | 746 | 2004 |
| Significant variability in response to inhaled corticosteroids for persistent asthma SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ... Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002 | 744 | 2002 |
| The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ... American journal of respiratory and critical care medicine 162 (1), 75-80, 2000 | 699 | 2000 |
| Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors CD De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, ... The Lancet 365 (9474), 1827-1829, 2005 | 620 | 2005 |
